Short Interest in HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE … – MarketBeat
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE – Get Rating) was the recipient of a significant decline in short interest in November. As of November 30th, there was short interest totalling 5,050,000 shares, a decline of 15.3% from the November 15th total of 5,960,000 shares. Based on an average trading volume of 1,120,000 shares, the days-to-cover ratio is presently 4.5 days. Approximately 6.7% of the shares of the stock are short sold.
HIVE Blockchain Technologies Trading Up 1.6 %
NASDAQ HIVE traded up $0.03 on Friday, hitting $1.89. 1,733,578 shares of the company were exchanged, compared to its average volume of 1,554,968. The company’s 50 day moving average price is $2.57 and its 200-day moving average price is $3.61. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.75 and a quick ratio of 3.75. The firm has a market capitalization of $156.92 million, a P/E ratio of -1.64 and a beta of 2.11. HIVE Blockchain Technologies has a twelve month low of $1.77 and a twelve month high of $15.80.
Wall Street Analyst Weigh In
Several equities research analysts have commented on the stock. Canaccord Genuity Group boosted their price target on shares of HIVE Blockchain Technologies from $5.50 to $7.00 in a research report on Monday, August 29th. Canaccord Genuity Group boosted their price target on shares of HIVE Blockchain Technologies from $5.50 to $7.00 and gave the stock a “buy” rating in a research report on Monday, August 29th. HC Wainwright dropped their price target on shares of HIVE Blockchain Technologies from $7.00 to $5.00 and set a “buy” rating on the stock in a research report on Monday, December 12th. TheStreet downgraded HIVE Blockchain Technologies from a “c” rating to a “d+” rating in a report on Thursday, September 1st. Finally, StockNews.com upgraded HIVE Blockchain Technologies to a “sell” rating in a report on Friday, October 21st.
Institutional Trading of HIVE Blockchain Technologies
Institutional investors and hedge funds have recently bought and sold shares of the stock. State Street Corp purchased a new position in HIVE Blockchain Technologies during the 2nd quarter valued at about $1,007,000. UBS Group AG grew its stake in HIVE Blockchain Technologies by 174.5% during the 3rd quarter. UBS Group AG now owns 17,829 shares of the company’s stock valued at $67,000 after acquiring an additional 11,333 shares in the last quarter. Tower Research Capital LLC TRC grew its stake in HIVE Blockchain Technologies by 154.6% during the 3rd quarter. Tower Research Capital LLC TRC now owns 15,072 shares of the company’s stock valued at $56,000 after acquiring an additional 9,153 shares in the last quarter. BlackRock Inc. grew its stake in HIVE Blockchain Technologies by 25.9% during the 3rd quarter. BlackRock Inc. now owns 82,303 shares of the company’s stock valued at $310,000 after acquiring an additional 16,951 shares in the last quarter. Finally, Almanack Investment Partners LLC. purchased a new position in HIVE Blockchain Technologies during the 3rd quarter valued at about $44,000. Institutional investors and hedge funds own 8.08% of the company’s stock.
About HIVE Blockchain Technologies
(Get Rating)
HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. It engages in the mining and sale of digital currencies, including Ethereum, Ethereum Classic, and Bitcoin. The company was formerly known as Leeta Gold Corp. and changed its name to HIVE Blockchain Technologies Ltd.
See Also
- Get a free copy of the StockNews.com research report on HIVE Blockchain Technologies (HIVE)
- MarketBeat: Week in Review 12/12 – 12/16
- Which Two Bluechip Tech Companies Have Raised Their Guidance?
- Should You Worry About Elon Musk Selling His Tesla Shares?
- Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
- This is no Time to Buy Lennar but the Time is Coming
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HIVE Blockchain Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and HIVE Blockchain Technologies wasn’t on the list.
While HIVE Blockchain Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.